Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis

被引：0
|
作者：
Ping Liu
Blair Capitano
Amy Stein
Ali A. El-Solh
机构：
[1] Global Established Pharma Business,Clinical Pharmacology
[2] Specialty Care,Medical Affairs
[3] Pfizer Inc.,Customer Solutions
[4] Biostatistics,Division of Pulmonary, Critical Care and Sleep Medicine
[5] Quintiles,VA Western New York Healthcare System
[6] University at Buffalo,undefined
[7] Medical Research,undefined
[8] Bldg. 20 (151) VISN02,undefined
来源：
BMC Nephrology | / 18卷
关键词：
Outcomes; Linezolid; Vancomycin; Pneumonia; MRSA; Renal function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
    E. De Cock
    W. A. Krueger
    S. Sorensen
    T. Baker
    J. Hardewig
    S. Duttagupta
    E. Müller
    A. Piecyk
    E. Reisinger
    A. Resch
    Infection, 2009, 37
  • [22] An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany
    Patel, Dipen A.
    Michel, Andre
    Stephens, Jennifer
    Weber, Bertram
    Petrik, Christian
    Charbonneau, Claudie
    INFECTION AND DRUG RESISTANCE, 2014, 7 : 273 - 280
  • [23] Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia
    Jung, Young Ju
    Koh, Younsuck
    Hong, Sang-Bum
    Chung, Joo Won
    Choi, Sang Ho
    Kim, Nam Joong
    Kim, Mi-Na
    Choi, Ik Su
    Han, Song Yi
    Kim, Won-Dong
    Yun, Sung-Cheol
    Lim, Chae-Man
    CRITICAL CARE MEDICINE, 2010, 38 (01) : 175 - 180
  • [24] Risk factors of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Torre-Cisneros, Julian
    Tejero Garcia, Rocio
    Natera Kindelan, Clara
    Font Ugalde, Pilar
    Franco Alvarez de Luna, Francisco
    Caston Osorio, Juan Jose
    Rivero Roman, Antonio
    Casal Roman, Manuel
    MEDICINA CLINICA, 2012, 138 (03): : 99 - 106
  • [25] Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients
    Chung, J.
    Oh, J. M.
    Cho, E. M.
    Jang, H. J.
    Hong, S. B.
    Lim, C. M.
    Koh, Y. S.
    ANAESTHESIA AND INTENSIVE CARE, 2011, 39 (06) : 1030 - 1037
  • [26] Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study
    Andrew F. Shorr
    Marya D. Zilberberg
    Scott T. Micek
    Marin H. Kollef
    Critical Care, 19
  • [27] Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan
    Kohno, S.
    Yamaguchi, K.
    Aikawa, N.
    Sumiyama, Y.
    Odagiri, S.
    Aoki, N.
    Niki, Y.
    Watanabe, S.
    Furue, M.
    Ito, T.
    Croos-Dabrera, R.
    Tack, K. J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1361 - 1369
  • [28] Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia
    Jung, Won Jai
    Kang, Young Ae
    Park, Moo Suk
    Park, Seon Cheol
    Leem, Ah Young
    Kim, Eun Young
    Chung, Kyung Soo
    Kim, Young Sam
    Kim, Se Kyu
    Chang, Joon
    Jung, Ji Ye
    BMC INFECTIOUS DISEASES, 2013, 13
  • [29] Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study
    Wang, Jann-Tay
    Hsu, Le-Yin
    Lauderdale, Tsai-Ling
    Fan, Wen-Chien
    Wang, Fu-Der
    PLOS ONE, 2015, 10 (12):
  • [30] Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?
    Claeys, Kimberly C.
    Lagnf, Abdalhamid M.
    Hallesy, Jessica A.
    Compton, Matthew T.
    Gravelin, Alison L.
    Davis, Susan L.
    Rybak, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1708 - 1716
12345